Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis
Clinical Scorecard: Pathological Characteristics Linked to Donor Genetics, Lesion Distribution, and Clinical Variability in Multiple Sclerosis
At a Glance
Category Detail
Condition Multiple Sclerosis Key Mechanisms Chronic inflammatory disease of the CNS with focal demyelinating lesions influenced by genetic susceptibility and pathological features. Target Population Individuals diagnosed with Multiple Sclerosis. Care Setting Post-mortem analysis and research in a specialized brain bank.
Key Highlights
Substantial inter-individual biological heterogeneity in MS pathology. Higher lesion load and mixed lesions correlate with faster disability accumulation. Donor-specific pathological features may reflect inflammatory and reparative processes. Guideline-Based Recommendations
Diagnosis
MS pathology confirmed by certified neuropathologist. Management
Standardized autopsy procedures and lesion classification systems for quantitative assessment. Monitoring & Follow-up
Assessment of lesion burden and type distributions across the CNS. Risks
Increased proportion of mixed lesions associated with faster disability progression. Patient & Prescribing Data
287 donors with MS from the Netherlands Brain Bank autopsy cohort.
Analysis of pathological features may inform understanding of disease progression.
Clinical Best Practices
Utilize standardized classification systems for MS lesions. Incorporate donor-specific pathological features in research to understand variability. Related Resources & Content
